Debbie Rigby rounds up the latest in research news Update on colchicine, 2017 Colchicine is currently approved for the treatment of gout. Studies indicate that it may be beneficial in a variety of other conditions, including other rheumatic diseases. Colchicine’s anti-inflammatory effects hold promise for prevention/management of cardiovascular conditions, including acute coronary syndromes. Rheumatology 2018;57:i4-i11.
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.